argenx SE (EBR:ARGX)
Belgium · Delayed Price · Currency is EUR 728.40
+22.80 (3.23%)
Oct 9, 2026, 5:35 PM CET
argenx SE Market Cap
argenx SE has a market cap or net worth of €45.55 billion as of October 9, 2026. It is the 483rd most valuable company in the world and the 3rd biggest in Belgium. Its market cap has increased by 8.31% in one year.
Market Cap
45.55B
Enterprise Value
41.06B
Revenue
4.65B
Global Rank
Country Rank
#3 Belgium
PE Ratio
31.75
ChartMarket Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 122.42M to 45.55B, an increase of 37,109.67%. That is a compound annual growth rate of 62.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 45.55B | 3.84% |
| Dec 31, 2025 | 43.87B | 21.11% |
| Dec 31, 2024 | 36.22B | 78.48% |
| Dec 29, 2023 | 20.29B | 5.32% |
| Dec 30, 2022 | 19.27B | 18.28% |
| Dec 31, 2021 | 16.29B | 42.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| UCB SA | 38.82B |
| Financière de Tubize | 7.66B |
| Onward Medical | 172.08M |
| Hyloris Pharmaceuticals | 111.16M |
| European Medical Solutions | 15.32M |
| Celyad Oncology | 9.62M |
| BioSenic | 1.31M |
| Oxurion NV | 140.74K |